Skip to main content

Together we are beating cancer

Donate now

CRUK Cambridge Cancer Centre

Showing 4 out of 4 results
Brain scans

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

by Sophie Wedekind | News | 23 October 2024

23 October 2024

CT scan of a glioblastoma brain tumour highlighted in one section of the brain.

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

by Sadaf Shafaghmotlagh | News | 24 September 2024

24 September 2024

A crowd of people looking concerned on a hot day.

More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier. More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier.

by Tim Gunn | News | 15 July 2024

15 July 2024

Lung adenocarcinoma cells

Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers. Researchers have developed a new model to study senescence in, and found that clearing a certain type of senescent cell from the tumour microenvironment could prevent some lung cancers.

by Jacob Smith | Analysis | 1 June 2023

1 June 2023